logo

For the Inventor, By the Inventor

La Jolla, CA, United States of America

Orexigen Therapeutics, Inc.


USPTO Granted Patents = 17



Trademarks = 5

Forward Citations = 346

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Gary Dennis Tollefson (9 out of 20 patents)

silverMedal Anthony A McKinney (8 out of 10 patents)

bronzeMedal Eckard Weber (6 out of 70 patents)

4.  Michael Alexander Cowley (4 out of 10 patents)

5.  Preston Klassen (4 out of 11 patents)

6.  Kristin Taylor (4 out of 15 patents)

7.  Rick Soltero (4 out of 5 patents)

8.  Richard Soltero (2 out of 13 patents)

9.  Thea Elise Dunzo (2 out of 2 patents)

10.  K Ranga R Krishnan (2 out of 6 patents)

11.  Kishore M Gadde (2 out of 5 patents)

12.  Eduardo Dunayevich (1 out of 5 patents)

13.  Simon Yau (5 patents)

14.  Susan McElroy (1 patent)

15.  Shawn Flanagan (0 patent)


17 patents:

1. 9801875 - Compositions and methods for weight loss in at risk patient populations (2017-10-31),
2. 9633575 - Methods of treating overweight and obesity (2017-04-25),
3. 9457005 - Compositions and methods for increasing insulin sensitivity (2016-10-04),
4. 9248123 - Methods of providing weight loss therapy in patients with major depression (2016-02-02),
5. 9125868 - Methods for administering weight loss medications (2015-09-08),
6. 9119850 - Compositions and methods for weight loss in at risk patient populations (2015-09-01),
7. 9107837 - Sustained release formulation of naltrexone (2015-08-18),
8. 8969371 - Compositions and methods for weight loss in at risk patient populations (2015-03-03),
9. 8916195 - Sustained release formulation of naltrexone (2014-12-23),
10. 8815889 - Compositions and methods for increasing insulin sensitivity (2014-08-26),
11. 8722085 - Methods for administering weight loss medications (2014-05-13),
12. 8318788 - Layered pharmaceutical formulations (2012-11-27),
13. 8088786 - Layered pharmaceutical formulations (2012-01-03),
14. 7462626 - Compositions for affecting weight loss (2008-12-09),
15. 7429580 - Compositions of an anticonvulsant and an antipsychotic drug and methods of using the same for affecting weight loss (2008-09-30),
Company Overview
Orexigen Therapeutics, Inc. is a biopharmaceutical company based in La Jolla, California, specializing in the development of innovative therapies for obesity and related metabolic disorders. The company focuses on advancing treatments that target the underlying mechanisms of weight management, aiming to improve patient outcomes through scientific research and clinical development. Orexigen is committed to addressing the growing global health challenge of obesity by leveraging its expertise in pharmacotherapy and metabolic science.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

17 Patents

#28 in La Jolla, CA

#4,515 in California

#18,840 in US

#35,918 in the World

La Jolla, CA (US)
La Jolla, CA, United States of America

Orexigen Therapeutics, Inc.

Forward Citations = 346

12 inventors:

goldMedal Gary Dennis Tollefson (9 out of 20 patents)

silverMedal Anthony A McKinney (8 out of 10 patents)

bronzeMedal Eckard Weber (6 out of 70 patents)

4.  Michael Alexander Cowley (4 out of 10 patents)

5.  Preston Klassen (4 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Orexigen Therapeutics, Inc.. Retrieved from https://idiyas.com/company/orexigen-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…